메뉴 건너뛰기
New England Journal of Medicine
Volumn 374, Issue 9, 2016, Pages 889-890
The authors reply
Author keywords

[No Author keywords available]
Indexed keywords

CABOZANTINIB; EVEROLIMUS; NIVOLUMAB; PAZOPANIB; SUNITINIB; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; RAPAMYCIN;
EID: 84959460813     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1515613     Document Type: Letter
Times cited : (13)
References (5)
  • 1
    • 84959525446 scopus 로고    scopus 로고
    • CheckMate 025 phase III trial: Outcomes by key baseline factors and prior therapy for nivolumab (NIVO) vs everolimus (Eve) in advanced renal cell carcinoma (RCC)
    • San Francisco, January 7-9 abstract
    • Motzer RJ, Sharma P, McDermott DF, et al. CheckMate 025 phase III trial: outcomes by key baseline factors and prior therapy for nivolumab (NIVO) vs everolimus (EVE) in advanced renal cell carcinoma (RCC). Presented at the 2016 Genitourinary Cancers Symposium, San Francisco, January 7-9, 2016. abstract.
    • (2016) Presented at the 2016 Genitourinary Cancers Symposium
    • Motzer, R.J.1    Sharma, P.2    McDermott, D.F.3
  • 2
    • 84947744637 scopus 로고    scopus 로고
    • Princeton, NJ: Bristol-Myers Squibb, November
    • Opdivo (nivolumab) injection (prescribing information). Princeton, NJ: Bristol-Myers Squibb, November 2015 (http://packageinserts.bms.com/pi/pi-opdivo.pdf).
    • (2015) Opdivo (Nivolumab) Injection (Prescribing Information)
  • 3
    • 84942243453 scopus 로고    scopus 로고
    • Rapid modification of the bone microenvironment following short-term treatment with cabozantinib in vivo
    • Haider MT, Hunter KD, Robinson SP, et al. Rapid modification of the bone microenvironment following short-term treatment with cabozantinib in vivo. Bone 2015; 81: 581-92.
    • (2015) Bone , vol.81 , pp. 581-592
    • Haider, M.T.1    Hunter, K.D.2    Robinson, S.P.3
  • 4
    • 84905919157 scopus 로고    scopus 로고
    • Prognostic significance of bone metastases and bisphos-phonate therapy in patients with renal cell carcinoma
    • McKay RR, Lin X, Perkins JJ, Heng DY, Simantov R, Choueiri TK. Prognostic significance of bone metastases and bisphos-phonate therapy in patients with renal cell carcinoma. Eur Urol 2014;66:502-9.
    • (2014) Eur Urol , vol.66 , pp. 502-509
    • McKay, R.R.1    Lin, X.2    Perkins, J.J.3    Heng, D.Y.4    Simantov, R.5    Choueiri, T.K.6
  • 5
    • 84946552683 scopus 로고    scopus 로고
    • Cabozantinib versus everolimus in advanced renal-cell carcinoma
    • Choueiri TK, Escudier B, Powles T, et al. Cabozantinib versus everolimus in advanced renal-cell carcinoma. N Engl J Med 2015;373:1814-23.
    • (2015) N Engl J Med , vol.373 , pp. 1814-1823
    • Choueiri, T.K.1    Escudier, B.2    Powles, T.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.